Over the past five years, leaders on both the clinical and business sides of radiology have learned the hard way that adaptability and flexibility are prized qualities required for survival.

In a comparison of gastrin-releasing peptide receptor (GRPR) bombesin analogs, F-18 aluminum flouride-labeled NODAGA-RM1 showed the most promise for PET imaging of prostate cancer, according to a study published online Nov. 6 in the Journal of Nuclear Medicine.

People fluent in two languages may be warding off the cognitive decline associated with dementia for up to six years longer than single-language speakers, according to a study published online Nov. 6 in Neurology.

Human nature being what it is, physician participation in Medicare’s Physician Quality Reporting System (PQRS) will likely accelerate as the agency phases incentives out and penalties in. The effect may prove especially conspicuous since the bonuses have been voluntary and modest. By contrast, the forfeitures will be automatic and, if paired with other pay-for-performance requirements, impossible to ignore.

Each year, a few images emerge from the masses as the most striking portraits of the newest molecular imaging research.

Tao is making headlines. The journal Neuron recently published a clinical study heralding a viable tau PET agent. Co-author Makoto Higuchi from the Molecular Imaging Center of the National Institute of Radiological Sciences in Chiba, Japan, provided us with an exclusive look into this game-changer that will no doubt inform new formulas for dementia imaging.

Cancer is often characterized as a serial murderer that needs to be struck down with brute force. But what researchers are slowly coming to understand is that this idea might actually make individual cancers stronger.

Cocaine addiction can ruin a person physically and financially, and with an estimated 1.4 million cocaine users in the U.S., thousands will become trapped by their habit. While previous research on the drug and its addictive potential were observational and subjective, imaging is reshaping how we see addiction—and how it will be treated.